CPI joins the Sustainable Medicines Partnership

The SMP is a not-for-profit private-public collaboration executing projects to make the use of medicines more sustainable and less wasteful. 

We accelerate the development, scale-up and commercialisation of deep tech and sustainable manufacturing solutions, including next-generation medicine manufacturing innovations, offering world-leading facilities and expertise in small molecules, biologics, and complex medicines.

Home to the Medicines Manufacturing Innovation Centre in Renfrewshire, Scotland, we’re creating agile, efficient, and sustainable supply chains by convening actors across the pharma industry ecosystem in a pre-competitive space and boosting adoption of industry 4.0 digitisation. 

In our collaboration with the SMP, the CPI-led Medicines Manufacturing Innovation Centre will help the global pharma ecosystem adopt novel technologies and processes to improve the sustainability of medicines, their manufacturing and associated supply chains. 

Dave Tudor, Managing Director of the CPI-led Medicines Manufacturing Innovation Centre, said:

“We’re excited to join the SMP as we have a shared vision, to improve sustainability through innovation. CPI’s technical programmes and Grand Challenges are helping to bring new pharma innovations to market, and reduce costs and waste within the industry. CPI, alongside SMP and its wide set of collaborators, will provide a significant impact on the sustainability of medicines globally and in the UK.”

Nazneen Rahman, CEO of YewMaker CEO and SMP Director, said:

“We are thrilled CPI has joined the SMP. CPI is a trusted partner of industry, academia, government, and the investment community with a long track record of turning ideas into reality and a strong commitment to sustainable medicines manufacturing solutions. We look forward to working together.”